Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-18

Clinical Trial Update: Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing tenofovir monotherapy to tenofovir combined with telbivudine for chronic hepatitis B; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telbivudine (telbivudine)
  • Tenofovir (Tenofovir)

Snippet

Sponsor: Seng Gee Lim | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN